Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma.
Journal article published in 2014 by
M. Jakovljevic,
M. Schwenkglenks,
F. Gutzwiller 
,
O. Milovanovic,
N. Rancic ,
M. Varjacic,
D. Stojadinovic,
A. Dagovic,
Klazien Matter-Walstra
,
O. Milovanovic,
N. Rancic ,
M. Varjacic,
D. Stojadinovic,
A. Dagovic,
Klazien Matter-Walstra
